Phase 2 Immunosuppression Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy
Immunosuppression
Linda Cendales50 enrolled1 locationNCT02310867
Recruiting
Phase 1Phase 2
Immune Tolerance Induction After Liver Transplantation
Liver TransplantationEnd Stage Liver DiseaseImmune Tolerance+6 more
University of California, Los Angeles12 enrolled1 locationNCT07269041
Recruiting
Phase 2Phase 3
Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus Placebo
Post-aggressive ImmunosuppressionAdult Patients Admitted to Intensive Care With Initial Severity (SOFA of the First 24 Hours Post-admission ≥ 6Adult Under Mechanical Ventilation, and Presenting an mHLA-DR Less Than 8,000AB/C
Assistance Publique - Hôpitaux de Paris170 enrolled2 locationsNCT06694740
Completed
Phase 2
The impact of perioperative administration of seasonal influenza vaccine and arginine-enriched immunonutrition on perioperative immune status (PaSIVI): A Feasibility and Pilot Study
Perioperative immunosuppressionCancer Surgery
Peter MacCallum Cancer Centre30 enrolled1 locationACTRN12622000706774
Recruiting
Phase 2
RFA Plus Carrizumab vs Carrizumab Alone for HCC
Radiofrequency AblationTumor ImmunityImmunosuppression
Second Affiliated Hospital, School of Medicine, Zhejiang University120 enrolled1 locationNCT04150744
Not Yet Recruiting
Phase 2
A trial of donor-derived cytotoxic T lymphocytes stimulated with an adenoviral vector containing the pp65 gene to prevent reactivation of cytomegalovirus following allogeneic stem cell transplantation for haematological malignancy
Immunosuppression post stem cell transplant for haematological malignancy
Sydney West Area Health Service60 enrolled1 locationACTRN12607000224426